FLUOGUIDE A/S DK -1 Total Assets
FLUOGUIDE A/S DK -1 total assets. Based on the latest financial reports, FLUOGUIDE A/S DK -1 (96X) holds total assets worth €88.29 Million EUR (≈ $103.22 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see FLUOGUIDE A/S DK -1 market cap and net worth for the company's overall valuation and market capitalisation.
Total Assets of FLUOGUIDE A/S DK -1 (2021–2025)
Total assets of FLUOGUIDE A/S DK -1 from 2021 to 2025. This chart illustrates how FLUOGUIDE A/S DK -1's total assets have evolved over time, based on quarterly financial data. See 96X live share price for real-time trading data and today's change.
FLUOGUIDE A/S DK -1 - Asset Composition Analysis
FLUOGUIDE A/S DK -1 Total Assets Breakdown (December 2025)
FLUOGUIDE A/S DK -1 total assets breakdown as of December 2025. FLUOGUIDE A/S DK -1's total assets of €88.29 Million consist of 98.3% current assets and 1.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 55.3% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €378.00K | 0.4% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how FLUOGUIDE A/S DK -1's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore FLUOGUIDE A/S DK -1 short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: FLUOGUIDE A/S DK -1's current assets represent 98.3% of total assets in 2025, a decrease from 99.1% in 2021.
- Cash Position: Cash and equivalents constituted 55.3% of total assets in 2025, down from 87.7% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 0.4% of total assets.
FLUOGUIDE A/S DK -1 Competitors by Total Assets
Key competitors of FLUOGUIDE A/S DK -1 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
CSL LTD SPON.ADR 2
F:CSJA
|
Germany | €38.45 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578
|
China | CN¥8.59 Billion |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278
|
China | CN¥3.21 Billion |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
PHARVARIS N.V. EO -12
F:9EN
|
Germany | €301.45 Million |
|
NANOBIOTIX S.A. SP.ADR
F:5NRA
|
Germany | €67.76 Million |
|
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513
|
China | CN¥3.82 Billion |
FLUOGUIDE A/S DK -1 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 15.15 | 5.39 | 11.48 |
| Quick Ratio | 15.15 | 5.39 | 11.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €81.02 Million | €21.59 Million | €30.03 Million |
FLUOGUIDE A/S DK -1 - Advanced Valuation Insights
This section examines the relationship between FLUOGUIDE A/S DK -1's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.27 |
| Latest Market Cap to Assets Ratio | 0.58 |
| Asset Growth Rate (YoY) | 211.1% |
| Total Assets | €88.29 Million |
| Market Capitalization | $50.84 Million USD |
Valuation Analysis
Below Book Valuation: The market values FLUOGUIDE A/S DK -1's assets below their book value (0.58x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: FLUOGUIDE A/S DK -1's assets grew by 211.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for FLUOGUIDE A/S DK -1 (2021–2025)
The table below shows the annual total assets of FLUOGUIDE A/S DK -1 from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €88.29 Million ≈ $103.22 Million |
+211.11% |
| 2024-12-31 | €28.38 Million ≈ $33.18 Million |
-4.15% |
| 2023-12-31 | €29.61 Million ≈ $34.62 Million |
-16.88% |
| 2022-12-31 | €35.62 Million ≈ $41.64 Million |
-33.18% |
| 2021-12-31 | €53.31 Million ≈ $62.32 Million |
-- |
About FLUOGUIDE A/S DK -1
FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatmen… Read more